Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study)

• Christian Daugaard Peters ,

  * E-mail: cdp@ana.au.dk

  Affiliations Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark

  ⨯
• Krista Dybtved Kjaergaard,

  Affiliations Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark

  ⨯
• Jens Dam Jensen,

  Affiliations Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark

  ⨯
• Kent Lodberg Christensen,

  Affiliation Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Charlotte Strandhave,

  Affiliation Department of Nephrology, Aalborg University Hospital, Aalborg, Denmark

  ⨯
• Ida Noerager Tietze,

  Affiliation Department of Medicine, Viborg Regional Hospital, Viborg, Denmark

  ⨯
• Marija Kristina Novosel,

  Affiliation Department of Medicine, Fredericia Hospital, Fredericia, Denmark

  ⨯
• Bo Martin Bibby,

  Affiliation Department of Biostatistics, Aarhus University, Aarhus, Denmark

  ⨯
• Bente Jespersen

  Affiliations Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark

  ⨯